# FDA Panel Narrowly Backs Four Peptides — Hims & Hers Stock in the Spotlight - Benzinga

*Источник: Benzinga*
*Дата: 2026-07-24*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNbkd3VFpCNnpMLS1hT3dCbVNqSEJfdDhOSFhjTkZDNmlsMjhKbGI0SDlUU3Q2bHM0cVNqVHRTUmViU2U4OEppZFludmNLV2R1dU01UzZEaVYtaEFMTnJPODFkTHdGUU1sSl9NR3BLdlBjakdmMFREQkNqRUFBS2NkSXVDNXJva21YTl85cnZqZURiSXpHOVh4TTRMVWswOExNTlFZcGdZLThCRUdmQ19RTFliWEJrY0VrZGZMZVpQX0gydUVyZ21UY3ZHZlE?oc=5" target="_blank">FDA Panel Narrowly Backs Four Peptides — Hims & Hers Stock in the Spotlight</a>&nbsp;&nbsp;<font color="#6f6f6f">Benzinga</font>

[Оригинал](https://www.benzinga.com/trading-ideas/movers/26/07/60664382/fda-panel-narrowly-backs-four-peptides-hims-hers-stock-in-the-spotlight)